PUBLISHER: Grand View Research | PRODUCT CODE: 1908506
PUBLISHER: Grand View Research | PRODUCT CODE: 1908506
The global bioplastics in diagnostic devices market size was estimated at USD 273.5 million in 2024 and is projected to reach USD 668.5 million by 2033, growing at a CAGR of 10.6% from 2025 to 2033. Product adoption began in lower-risk, high-volume disposable components where regulatory barriers are lower, and cost sensitivity is high, notably lateral-flow assay (LFA) housings, rapid test kits, and non-sterile ancillary components.
The market is an intersection of two dynamics: rapid growth in point-of-care testing and increasing procurement pressure on healthcare providers to reduce single-use plastic waste. Geographically, the market is strongest in regions with mature IVD industries and sustainability procurement, while emerging markets trail in adoption due to price sensitivity and the availability of medical-grade biopolymers. Market value today is still small relative to the broader IVD consumables market, but growth rates are materially higher, driven by OEM sustainability commitments, corporate ESG targets, and increasing availability of medical-grade bioplastic resins and qualified converters.
Global Bioplastics In Diagnostic Devices Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bioplastics in diagnostic devices market report based on material, application, and region: